Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

BACKGROUND: Warfarin is commonly used as a secondary prevention of stroke in patients with atrial fibrillation (AF). However, limitations have been observed even with the use of this medication. Recently, several newer direct oral anticoagulants (DOACs) have been approved for use by the food and dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Bundhun, Pravesh Kumar, Soogund, Mohammad Zafooruddin Sani, Teeluck, Abhishek Rishikesh, Pursun, Manish, Bhurtu, Akash, Huang, Wei-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216587/
https://www.ncbi.nlm.nih.gov/pubmed/28056795
http://dx.doi.org/10.1186/s12872-016-0449-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216587/
https://www.ncbi.nlm.nih.gov/pubmed/28056795
http://dx.doi.org/10.1186/s12872-016-0449-2

Ejemplares similares